Fact CheckerSign in

NCT04095195Recruiting

Registry of Subjects at Risk of Pancreatic Cancer

Italian Registry of Families At Risk of Pancreatic Cancer

Source: ClinicalTrials.gov · Last updated 13 Jan 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.

Status (registry)
Recruiting
Study type
Observational
Enrollment
1000 (estimated)
First submitted
17 Sept 2019
Start date
20 Aug 2019
Primary completion date
20 Aug 2044
Lead sponsor
Associazione Italiana per lo Studio del Pancreas
NCT number
NCT04095195

What you commit to

  • Study type: Observational
  • Planned participants: 1000
  • From 20 Aug 2019 to the primary completion date, 20 Aug 2044
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \- pregnancy

Who the study is looking for

  • individuals with at least two relatives suffering from pancreatic cancer, with at least 1 first-degree and until the third-degree
  • subjects with known genetic mutation of BRCA2, BRCA1, p16, PALB2 with at least 1 first- or 2nd-degree relative suffering from pancreatic cancer
  • subjects suffering from FAMMM Syndrome
  • subjects suffering from Peutz-Jeghers Syndrome
  • subjects suffering from PRSS-1- or CFTR- or SPINK-1- related pancreatitis
  • subjects suffering from Lynch syndrome with at least 1 first- or 2nd-degree relative suffering from pancreatic cancer
  • 45 years or 10 years younger than the youngest index case of pancreatic cancer in the family for familial cases
  • 40 years or 5 years younger than the youngest index case of pancreatic cancer for subjects suffering from hereditary/genetic pancreatitis, Lynch syndrome, or carrying a known BRCA 1/2, PALB2, p16 genetic mutation with familiarity for pancreatic cancer
  • 30 years for subjects suffering from FAMMM, Peutz-Jeghers syndrome

Age in the registry: 18 years to 80 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
San Raffele Vita Salute University Hospital
Coordinator of this site? Confirm its status
MilanItalyRecruiting
Ospedale Pederzoli
Coordinator of this site? Confirm its status
Peschiera del GardaItalyRecruiting
Istituto Clinico Humanitas
Coordinator of this site? Confirm its status
RozzanoItalyRecruiting
Chirurgia Generale e del Pancreas
Coordinator of this site? Confirm its status
VeronaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.